
Cost‑effectiveness of precision cancer medicine‑current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)
Author(s) -
Konstantinos Christofyllakis,
Joerg Thomas Bittenbring,
Lorenz Thurner,
Manfred Ahlgrimm,
Stephan Stilgenbauer,
Moritz Bewarder,
Dominic KadduMulindwa
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2453
Subject(s) - precision medicine , cancer medicine , clinical trial , personalized medicine , medicine , profiling (computer programming) , cancer , oncology , bioinformatics , cost effectiveness , clinical practice , targeted therapy , intensive care medicine , computational biology , risk analysis (engineering) , computer science , biology , pathology , operating system , family medicine